English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 24 January 2020, 12:00 HKT/SGT
Share:
New Disinfectant Stops Spread of Virus, Including Coronavirus Strain from China

SYDNEY, AU, Jan 24, 2020 - (ACN Newswire) - Australian researcher Steven Kritzler says his Evocide Extra disinfectant is able to stop the spread of virus, as in the present outbreak in Wuhan City, China. This new strain of Coronavirus is a SARS-like virus that has caused hundreds of infections in China, and has spread to Thailand, Japan and South Korea.

Steven Kritzler of Novapharm Research (Aus) Pty. Ltd.

"Both the Wuhan virus, known as 2019-nCoV, and SARS belong to the family of viruses known as Coronaviridae, which can be deactivated by many materials, such as Evocide Extra," says Kritzler, who is based at Novapharm Research near Sydney, and is a committee member of the Australian Therapeutic Goods Administration (TGA).

Kritzler garnered attention at the Symposium on Advanced Infection Control in November when his Evocide Extra disinfectant formulation was presented. "Coronavirus is a type of enveloped virus -- a virus that develops viruses. My formulation can deactivate any virus, including enveloped and non-enveloped viruses."

"Coronavirus is microscopic, hence face masks alone cannot effectively prevent spreading the virus. I suggest that the best way to protect from spreading the virus is to wash your hands regularly, for example when you touch the door handle. And remember to use the disinfectants in time," says Kritzler.

Southern Cross, another formulation by Kritzler, are eco-friendly skin and hard surface disinfectant paper wipes that can deactivate viruses such as HIV (human immunodeficiency virus), hand-foot-mouth (EV71), influenza A (H1N1) and measles, and like Evocide can kill 99.999% of bacterial pathogens including super bacteria.

The Chinese Spring Festival holiday begins later this week, increasing the risk of spread of the new virus. The holiday period typically sees hundreds of millions of Chinese traveling throughout the country and overseas.

Contact: Kenny Kang, kz@fromau.com
Southern Cross Biotechnology Pty Ltd.

Topic: Press release summary Sectors: Environment, ESG, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase  
Apr 25, 2024 21:00 HKT/SGT
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross  
Apr 25, 2024 20:40 HKT/SGT
Q2 Metals Announces Assay Results from Its 2023 Inaugural Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada  
Apr 25, 2024 19:09 HKT/SGT
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024  
Thursday, April 25, 2024 5:21:00 PM
MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park  
Thursday, April 25, 2024 4:45:00 PM
8 in 10 Singapore businesses experienced more change in last 4 years than previous two decades: HubSpot Research  
Apr 25, 2024 16:00 HKT/SGT
GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series  
Thursday, April 25, 2024 3:50:00 PM
Toyota Exhibiting at Beijing Motor Show 2024  
Thursday, April 25, 2024 3:25:00 PM
CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program  
Apr 25, 2024 13:07 HKT/SGT
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada  
Thursday, April 25, 2024 10:10:00 AM
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575